or Try an Advanced Search...

    Technical Analysis for NYR - Nyrada Inc.

    Grade Last Price % Change Price Change
    B 0.105 5.00% 0.005
    NYR closed up 5.0 percent on Thursday, November 21, 2024, on 13 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Down
    Historical NYR trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.00%
    NR7 Range Contraction 5.00%
    Narrow Range Bar Range Contraction 5.00%
    Doji - Bullish? Reversal 5.00%
    Stochastic Reached Oversold Weakness 5.00%
    Earnings Movers Other 5.00%
    Wide Bands Range Expansion 5.00%
    Oversold Stochastic Weakness 5.00%
    Older End-of-Day Signals for NYR ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 7 hours ago
    Possible NR7 1 day ago
    Up 1% 1 day ago
    Possible NR7 2 days ago
    Rose Above 10 DMA 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NYR Chart by TradingView
    Basic chart:

    Profile

    Nyrada Inc (NYR) is a preclinical stage, drug development company. The Company specialises in the development of novel small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. It focuses on areas of substantial unmet clinical need and has identified drug candidates with therapeutic and commercial potential, where few if any, effective or well-tolerated therapies exist. It currently has three wholly-owned drug programs:
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Disease Diseases Drugs Drug Development

    Is NYR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.17
    52 Week Low 0.018
    Average Volume 1,052,827
    200-Day Moving Average 0.073
    50-Day Moving Average 0.097
    20-Day Moving Average 0.113
    10-Day Moving Average 0.107
    Average True Range 0.008
    RSI (14) 48.98
    ADX 17.82
    +DI 28.429
    -DI 29.973
    Chandelier Exit (Long, 3 ATRs) 0.132
    Chandelier Exit (Short, 3 ATRs) 0.123
    Upper Bollinger Bands 0.132
    Lower Bollinger Band 0.094
    Percent B (%b) 0.28
    BandWidth 33.539
    MACD Line 0.000
    MACD Signal Line 0.003
    MACD Histogram -0.0027
    Fundamentals Value
    Market Cap 11.49 Million
    Num Shares 109 Million
    EPS -99999.99
    Price-to-Earnings (P/E) Ratio 0.00
    Price-to-Sales 0.00
    Price-to-Book 4.35
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.113
    Resistance 3 (R3) 0.112 0.108 0.111
    Resistance 2 (R2) 0.108 0.106 0.109 0.111
    Resistance 1 (R1) 0.107 0.105 0.108 0.108 0.110
    Pivot Point 0.103 0.103 0.104 0.104 0.103
    Support 1 (S1) 0.102 0.101 0.103 0.103 0.100
    Support 2 (S2) 0.098 0.100 0.099 0.099
    Support 3 (S3) 0.097 0.098 0.099
    Support 4 (S4) 0.098